More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$278131992
EPS
-0.5
P/E ratio
--
Price to sales
0.25
Dividend yield
--
Beta
0.422506
Previous close
$8.61
Today's open
$8.66
Day's range
$8.40 - $8.75
52 week range
$7.43 - $18.30
show more
CEO
John A. Martins
Employees
8205
Headquarters
Boca Raton, FL
Exchange
Nasdaq Global Select
Shares outstanding
32759952
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Cross Country Healthcare: The Failed Merger Is Disappointing, But Selling Here Would Be A Mistake
Cross Country Healthcare saw its merger with Aya Healthcare collapse after the government shutdown pushed back the HSR waiting period expiration date. CCRN will receive a $20 million termination fee from Aya, adding to an already formidable cash position. Management has announced that it will immediately undergo up to $40 million in share buybacks, capitalizing on a low stock price.
Seeking Alpha • Dec 11, 2025

Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country Healthcare”) (Nasdaq: CCRN) today announced the termination of its Agreement and Plan of Merger (the “Merger Agreement” and, the transactions contemplated thereby, the “Aya Merger”) with Aya Holdings II Inc., a Delaware corporation (“Parent”), Spark Merger Sub One Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and, solely for purposes of Section 11.14 thereto.
Business Wire • Dec 4, 2025

Cross Country Healthcare Announces Third Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information: Variance Variance Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052 (21 )% (9 )% Gross profit margin* 20.4 % — bps — bps Net loss attributable to common stockholders $ (4,774 ) (287 )% 28 % Diluted EPS.
Business Wire • Nov 12, 2025

Cross Country Healthcare (CCRN) Lags Q3 Earnings and Revenue Estimates
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.12 per share a year ago.
Zacks Investment Research • Nov 13, 2025

Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country announced today that its marketing team has been named the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards.
Business Wire • Oct 22, 2025

KELYA or CCRN: Which Is the Better Value Stock Right Now?
Investors interested in Staffing Firms stocks are likely familiar with Kelly Services (KELYA) and Cross Country Healthcare (CCRN). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Oct 13, 2025

New Strong Sell Stocks for October 1st
AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.
Zacks Investment Research • Oct 1, 2025

New Strong Sell Stocks for August 20th
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
Zacks Investment Research • Aug 20, 2025

CCRN Earnings Drop 19%
Cross Country Healthcare (CCRN 2.02%), a major provider of healthcare staffing solutions, reported its second quarter results on August 6, 2025. The company reported a substantial miss on both GAAP revenue and non-GAAP EPS.
The Motley Fool • Aug 7, 2025

Cross Country Healthcare Announces Second Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information: Variance Variance Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2025 Revenue $ 274,072 (19 )% (7 )% Gross profit margin* 20.4 % (40 )bps 40 bps Net loss attributable to common stockholders $ (6,659 ) (59 )% (1,259 )% Diluted.
Business Wire • Aug 6, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Cross Country Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.